» Articles » PMID: 33731683

RNA Decay in Processing Bodies is Indispensable for Adipogenesis

Overview
Journal Cell Death Dis
Date 2021 Mar 18
PMID 33731683
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The RNA decay pathway plays key regulatory roles in cell identities and differentiation processes. Although adipogenesis is transcriptionally and epigenetically regulated and has been thoroughly investigated, how RNA metabolism that contributes to the stability of phenotype-shaping transcriptomes participates in differentiation remains elusive. In this study, we investigated Ddx6, an essential component of processing bodies (PBs) that executes RNA decay and translational repression in the cytoplasm and participates in the cellular transition of reprogramming. Upon adipogenic induction, Ddx6 dynamically accumulated to form PBs with a binding partner, 4E-T, at the early phase prior to emergence of intracellular lipid droplets. In contrast, preadipocytes with Ddx6 knockout (KO) or 4E-T knockdown (KD) failed to generate PBs, resulting in significant suppression of adipogenesis. Transcription factors related to preadipocytes and negative regulators of adipogenesis that were not expressed under adipogenic stimulation were maintained in Ddx6-KO and 4E-T-KD preadipocytes under adipogenic induction. Elimination of Dlk1, a major negative regulator of adipogenesis, in 3T3L1 Ddx6-KO cells did not restore adipogenic differentiation capacity to any extent. Similar to murine cells, human primary mesenchymal stem cells, which can differentiate into adipocytes upon stimulation with adipogenic cocktails, required DDX6 to maturate into adipocytes. Therefore, RNA decay of the entire parental transcriptome, rather than removal of a strong negative regulator, could be indispensable for adipogenesis.

Citing Articles

RNA sequestration in P-bodies sustains myeloid leukaemia.

Kodali S, Proietti L, Valcarcel G, Lopez-Rubio A, Pessina P, Eder T Nat Cell Biol. 2024; 26(10):1745-1758.

PMID: 39169219 DOI: 10.1038/s41556-024-01489-6.


Transcriptomic and Proteomic Analysis Reveals the Potential Role of RBMS1 in Adipogenesis and Adipocyte Metabolism.

Dairi G, Al Mahri S, Benabdelkamel H, Alfadda A, Alswaji A, Rashid M Int J Mol Sci. 2023; 24(14).

PMID: 37511060 PMC: 10379198. DOI: 10.3390/ijms241411300.


A novel mRNA decay inhibitor abolishes pathophysiological cellular transition.

Kami D, Ishizaki T, Taya T, Katoh A, Kouji H, Gojo S Cell Death Discov. 2022; 8(1):278.

PMID: 35672286 PMC: 9174231. DOI: 10.1038/s41420-022-01076-4.


Regulatory mechanisms of the early phase of white adipocyte differentiation: an overview.

Audano M, Pedretti S, Caruso D, Crestani M, De Fabiani E, Mitro N Cell Mol Life Sci. 2022; 79(3):139.

PMID: 35184223 PMC: 8858922. DOI: 10.1007/s00018-022-04169-6.

References
1.
Fraga de Andrade I, Mehta C, Bresnick E . Post-transcriptional control of cellular differentiation by the RNA exosome complex. Nucleic Acids Res. 2020; 48(21):11913-11928. PMC: 7708067. DOI: 10.1093/nar/gkaa883. View

2.
dAmati G, di Gioia C, Giordano C, Gallo P . Myocyte transdifferentiation: a possible pathogenetic mechanism for arrhythmogenic right ventricular cardiomyopathy. Arch Pathol Lab Med. 2000; 124(2):287-90. DOI: 10.5858/2000-124-0287-MT. View

3.
Ayache J, Benard M, Ernoult-Lange M, Minshall N, Standart N, Kress M . P-body assembly requires DDX6 repression complexes rather than decay or Ataxin2/2L complexes. Mol Biol Cell. 2015; 26(14):2579-95. PMC: 4501357. DOI: 10.1091/mbc.E15-03-0136. View

4.
Adjibade P, Mazroui R . Control of mRNA turnover: implication of cytoplasmic RNA granules. Semin Cell Dev Biol. 2014; 34:15-23. DOI: 10.1016/j.semcdb.2014.05.013. View

5.
Beffagna G, Occhi G, Nava A, Vitiello L, Ditadi A, Basso C . Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res. 2005; 65(2):366-73. DOI: 10.1016/j.cardiores.2004.10.005. View